ACC 22: Results from the POISE-3 Trial | Dr Philip J Devereaux

Подробнее о видео

Watch on Radcliffe Cardiology:

In this short interview from our coverage of the ACC 22 late-breaking trials, Dr PJ Devereaux (McMaster University, ON, CA) discusses the POISE-3 trial which was a large international, non-inferiority randomised controlled trial evaluating the efficacy and safety of tranexamic acid (TXA) versus placebo for controlling perioperative bleeding in the noncardiac surgical setting (NCT03505723).

Discussion Points:
-Importance of the Trial
-Study Design and Patient Cohort
-Study Outcomes
-Take-home Messages for Clinicians
-Ongoing trials/studies to Confirm the Use of Tranexamic Acid in this Patient Population

Recorded remotely from ACC, Washington DC, 2022.
Interviewer: Mirjam Boros

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.